Holdings of BIOTECHNOLOGY ULTRASECTOR PROFUND
ProFunds · Original filing · Compare with another fund · Report an error
- Net assets
- 118.7M $ including 93M $ in equities, 78.4 %
- Positions
- 147 in 7 countries
- Top ten
- 11.0 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Apogee Therapeutics Inc | 11,447 | 1.5M $ | 1.29 % |
| 2 | ORUKA THERAPEUTICS INC | 14,788 | 1.4M $ | 1.20 % |
| 3 | Dianthus Therapeutics Inc | 12,390 | 1.3M $ | 1.12 % |
| 4 | Erasca Inc | 70,819 | 1.3M $ | 1.08 % |
| 5 | TWIST BIOSCIENCE CORP | 13,972 | 1.3M $ | 1.08 % |
| 6 | KYMERA THERAPEUTICS INC | 12,103 | 1.3M $ | 1.05 % |
| 7 | Spyre Therapeutics Inc | 12,611 | 1.2M $ | 1.04 % |
| 8 | REVOLUTION MEDICINES INC | 6,567 | 1.2M $ | 1.04 % |
| 9 | CG ONCOLOGY INC | 17,241 | 1.2M $ | 1.03 % |
| 10 | Protagonist Therapeutics Inc | 8,952 | 1.2M $ | 1.03 % |
| 11 | Praxis Precision Medicines Inc | 3,934 | 1.2M $ | 1.02 % |
| 12 | Regeneron Pharmaceuticals Inc | 1,574 | 1.2M $ | 1.01 % |
| 13 | COGENT BIOSCIENCES INC | 30,174 | 1.2M $ | 0.99 % |
| 14 | NATERA INC | 4,373 | 1.2M $ | 0.99 % |
| 15 | Arrowhead Pharmaceuticals Inc | 13,387 | 1.1M $ | 0.95 % |
| 16 | TRAVERE THERAPEUTICS INC | 20,258 | 1.1M $ | 0.95 % |
| 17 | Roivant Sciences Ltd | 33,328 | 1.1M $ | 0.95 % |
| 18 | Relay Therapeutics Inc | 59,954 | 1.1M $ | 0.95 % |
| 19 | MODERNA INC | 20,588 | 1.1M $ | 0.95 % |
| 20 | VAXCYTE INC | 20,847 | 1.1M $ | 0.95 % |
| 21 | Bridgebio Pharma Inc | 14,047 | 1.1M $ | 0.95 % |
| 22 | Halozyme Therapeutics Inc | 13,431 | 1.1M $ | 0.93 % |
| 23 | Rhythm Pharmaceuticals Inc | 11,047 | 1.1M $ | 0.92 % |
| 24 | CYTOKINETICS INC | 14,117 | 1.1M $ | 0.92 % |
| 25 | Viking Therapeutics Inc | 34,121 | 1.1M $ | 0.91 % |
| 26 | Amgen Inc | 2,804 | 1.1M $ | 0.91 % |
| 27 | Incyte Corp | 8,984 | 1.1M $ | 0.90 % |
| 28 | MIRUM PHARMACEUTICALS INC | 10,073 | 1.1M $ | 0.90 % |
| 29 | Alkermes PLC | 21,598 | 1.1M $ | 0.89 % |
| 30 | TG THERAPEUTICS INC | 20,310 | 1.1M $ | 0.89 % |
| 31 | AbbVie Inc | 4,209 | 1.1M $ | 0.89 % |
| 32 | Vertex Pharmaceuticals Inc | 2,173 | 1M $ | 0.87 % |
| 33 | Krystal Biotech Inc | 3,031 | 1M $ | 0.87 % |
| 34 | Insmed Inc | 10,305 | 1M $ | 0.86 % |
| 35 | Scholar Rock Holding Corp | 21,476 | 1M $ | 0.86 % |
| 36 | Gilead Sciences Inc | 7,794 | 1M $ | 0.86 % |
| 37 | BioMarin Pharmaceutical Inc | 16,857 | 1M $ | 0.85 % |
| 38 | uniQure NV | 22,789 | 994.3K $ | 0.84 % |
| 39 | DYNE THERAPEUTICS INC | 39,481 | 994.1K $ | 0.84 % |
| 40 | Biogen Inc | 4,875 | 989.4K $ | 0.83 % |
| 41 | Neurocrine Biosciences Inc | 5,886 | 981.8K $ | 0.83 % |
| 42 | ACADIA Pharmaceuticals Inc | 37,819 | 978.4K $ | 0.82 % |
| 43 | Exelixis Inc | 18,006 | 954.9K $ | 0.80 % |
| 44 | IMMUNOVANT INC | 24,501 | 946.2K $ | 0.80 % |
| 45 | Madrigal Pharmaceuticals Inc | 2,009 | 938.8K $ | 0.79 % |
| 46 | GRAIL Inc | 13,555 | 929.3K $ | 0.78 % |
| 47 | Celcuity Inc | 10,730 | 926.9K $ | 0.78 % |
| 48 | Summit Therapeutics Inc | 70,875 | 922.8K $ | 0.78 % |
| 49 | CRISPR Therapeutics AG | 19,152 | 919.1K $ | 0.77 % |
| 50 | United Therapeutics Corp | 1,740 | 900.8K $ | 0.76 % |
| 51 | PTC Therapeutics Inc | 12,909 | 877.9K $ | 0.74 % |
| 52 | Ultragenyx Pharmaceutical Inc | 34,869 | 868.6K $ | 0.73 % |
| 53 | IMMUNITYBIO INC | 118,825 | 852K $ | 0.72 % |
| 54 | SELLAS Life Sciences Group Inc | 82,286 | 823.7K $ | 0.69 % |
| 55 | Beam Therapeutics Inc | 32,108 | 819.4K $ | 0.69 % |
| 56 | BioCryst Pharmaceuticals Inc | 90,976 | 817K $ | 0.69 % |
| 57 | VERA THERAPEUTICS INC | 25,201 | 809K $ | 0.68 % |
| 58 | Ideaya Biosciences Inc | 22,004 | 781.1K $ | 0.66 % |
| 59 | Denali Therapeutics Inc | 33,047 | 760.7K $ | 0.64 % |
| 60 | Tango Therapeutics Inc | 27,490 | 747.2K $ | 0.63 % |
| 61 | Arcutis Biotherapeutics Inc | 27,707 | 744.2K $ | 0.63 % |
| 62 | Celldex Therapeutics Inc | 19,262 | 733.1K $ | 0.62 % |
| 63 | VIRIDIAN THERAPEUTICS INC | 37,302 | 705.8K $ | 0.59 % |
| 64 | Disc Medicine Inc | 9,122 | 702.4K $ | 0.59 % |
| 65 | ARCUS BIOSCIENCES INC | 24,602 | 693.5K $ | 0.58 % |
| 66 | Mineralys Therapeutics Inc | 26,819 | 684.4K $ | 0.58 % |
| 67 | IONIS PHARMACEUTICALS INC | 12,914 | 668.6K $ | 0.56 % |
| 68 | ALNYLAM PHARMACEUTICALS INC | 3,251 | 668.1K $ | 0.56 % |
| 69 | Veracyte Inc | 14,229 | 659.1K $ | 0.56 % |
| 70 | Immunome Inc | 28,528 | 649.3K $ | 0.55 % |
| 71 | Syndax Pharmaceuticals Inc | 33,542 | 639K $ | 0.54 % |
| 72 | Recursion Pharmaceuticals Inc | 210,477 | 631.4K $ | 0.53 % |
| 73 | SAREPTA THERAPEUTICS INC | 42,415 | 630.3K $ | 0.53 % |
| 74 | ADMA Biologics Inc | 74,090 | 626.8K $ | 0.53 % |
| 75 | Kodiak Sciences Inc | 14,257 | 592.8K $ | 0.50 % |
| 76 | Intellia Therapeutics Inc | 54,738 | 584.6K $ | 0.49 % |
| 77 | Agios Pharmaceuticals Inc | 19,065 | 572.3K $ | 0.48 % |
| 78 | Iovance Biotherapeutics Inc | 138,193 | 562.4K $ | 0.47 % |
| 79 | Nurix Therapeutics Inc | 23,449 | 544.3K $ | 0.46 % |
| 80 | PALVELLA THERAPEUTICS INC | 3,897 | 541.8K $ | 0.46 % |
| 81 | Novavax Inc | 71,547 | 523.7K $ | 0.44 % |
| 82 | Vericel Corp | 11,387 | 523.3K $ | 0.44 % |
| 83 | Biohaven Ltd | 36,145 | 488K $ | 0.41 % |
| 84 | CareDx Inc | 10,901 | 476.5K $ | 0.40 % |
| 85 | Stoke Therapeutics Inc | 15,004 | 433K $ | 0.36 % |
| 86 | Precigen Inc | 67,557 | 423.6K $ | 0.36 % |
| 87 | TYRA BIOSCIENCES INC | 13,276 | 423.2K $ | 0.36 % |
| 88 | Vir Biotechnology Inc | 47,154 | 408.4K $ | 0.34 % |
| 89 | ZENAS BIOPHARMA INC | 12,867 | 404.5K $ | 0.34 % |
| 90 | AnaptysBio Inc | 7,500 | 400.2K $ | 0.34 % |
| 91 | First Tracks Biotherapeutics Inc | 8,871 | 390.7K $ | 0.33 % |
| 92 | Absci Corp | 49,479 | 384.9K $ | 0.32 % |
| 93 | Hyperliquid Strategies Inc | 60,350 | 374.8K $ | 0.32 % |
| 94 | Cullinan Therapeutics Inc | 22,670 | 374.1K $ | 0.32 % |
| 95 | Xencor Inc | 18,495 | 373.8K $ | 0.31 % |
| 96 | Corvus Pharmaceuticals Inc | 27,953 | 370.7K $ | 0.31 % |
| 97 | VOR BIOPHARMA INC | 16,745 | 354.2K $ | 0.30 % |
| 98 | AVALO THERAPEUTICS INC | 19,350 | 353.1K $ | 0.30 % |
| 99 | Ardelyx Inc | 70,717 | 350K $ | 0.29 % |
| 100 | ORIC Pharmaceuticals Inc | 31,133 | 344.6K $ | 0.29 % |
Sector breakdown
- Health care 14.0 %
- Unattributed 86.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 94.7 %
- Ireland 1.3 %
- Bermuda 1.2 %
- Netherlands 1.1 %
- Switzerland 1.0 %
- British Virgin Islands 0.5 %
- Cayman Islands 0.2 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 140 | 88.1M $ | 94.73 % |
| 2 | Ireland | 2 | 1.2M $ | 1.26 % |
| 3 | Bermuda | 1 | 1.1M $ | 1.21 % |
| 4 | Netherlands | 1 | 994.3K $ | 1.07 % |
| 5 | Switzerland | 1 | 919.1K $ | 0.99 % |
| 6 | British Virgin Islands | 1 | 488K $ | 0.52 % |
| 7 | Cayman Islands | 1 | 197.6K $ | 0.21 % |
Cite this page
Titelia. "Holdings of BIOTECHNOLOGY ULTRASECTOR PROFUND". https://titelia.com/en/funds/S000003107